accountstudy of an imaging drug for Alzheimer's disease. In a letter published in the Journal of the American Medical Association, Public Citizen criticized a January 19 study that assessed the effectiveness of brain scans using Lilly's Amyvid, an experimental...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to Public Citizen: Key data left out of Alzheimer's study
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account